-
-
-
-
-
-
-
Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock
-
-
-
-
-
-
-
Apyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring Systemâ„¢ for Power Liposuction
-
-
-
-
-
-
-
Apyx Medical launches Renuvion device in China through distributor deal
-
-
-
-
-
-
-
Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures
-
-
-
-
-
-
-
Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring Systemâ„¢
-
-
-
-
-
-
-
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
-
-
-
-
-
-
-
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

